» Articles » PMID: 34758846

Investigation on Factors Associated with Ovarian Cancer: an Umbrella Review of Systematic Review and Meta-analyses

Overview
Journal J Ovarian Res
Publisher Biomed Central
Date 2021 Nov 11
PMID 34758846
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Following cervical and uterine cancer, ovarian cancer (OC) has the third rank in gynecologic cancers. It often remains non-diagnosed until it spreads throughout the pelvis and abdomen. Identification of the most effective risk factors can help take prevention measures concerning OC. Therefore, the presented review aims to summarize the available studies on OC risk factors. A comprehensive systematic literature search was performed to identify all published systematic reviews and meta-analysis on associated factors with ovarian cancer. Web of Science, Cochrane Library databases, and Google Scholar were searched up to 17th January 2020. This study was performed according to Smith et al. methodology for conducting a systematic review of systematic reviews. Twenty-eight thousand sixty-two papers were initially retrieved from the electronic databases, among which 20,104 studies were screened. Two hundred seventy-seven articles met our inclusion criteria, 226 of which included in the meta-analysis. Most commonly reported genetic factors were MTHFR C677T (OR=1.077; 95 % CI (1.032, 1.124); P-value<0.001), BSML rs1544410 (OR=1.078; 95 %CI (1.024, 1.153); P-value=0.004), and Fokl rs2228570 (OR=1.123; 95 % CI (1.089, 1.157); P-value<0.001), which were significantly associated with increasing risk of ovarian cancer. Among the other factors, coffee intake (OR=1.106; 95 % CI (1.009, 1.211); P-value=0.030), hormone therapy (RR=1.057; 95 % CI (1.030, 1.400); P-value<0.001), hysterectomy (OR=0.863; 95 % CI (0.745, 0.999); P-value=0.049), and breast feeding (OR=0.719, 95 % CI (0.679, 0.762) and P-value<0.001) were mostly reported in studies. Among nutritional factors, coffee, egg, and fat intake significantly increase the risk of ovarian cancer. Estrogen, estrogen-progesterone, and overall hormone therapies also are related to the higher incidence of ovarian cancer. Some diseases, such as diabetes, endometriosis, and polycystic ovarian syndrome, as well as several genetic polymorphisms, cause a significant increase in ovarian cancer occurrence. Moreover, other factors, for instance, obesity, overweight, smoking, and perineal talc use, significantly increase the risk of ovarian cancer.

Citing Articles

The Association Between Physical Activity and Uterine Leiomyoma and Its Symptoms: A Systematic Review and Meta-Analysis.

Birolim M, Souza S, Rodrigues R, da Silva D, Martinez-Vizcaino V, Mesas A Health Sci Rep. 2025; 8(2):e70487.

PMID: 39995801 PMC: 11847712. DOI: 10.1002/hsr2.70487.


Development and Validation of Prognostic Characteristics Associated With Chromatin Remodeling-Related Genes in Ovarian Cancer.

Chen G, Li W, Guo J, Liu L, Wang Y Cancer Med. 2025; 14(3):e70634.

PMID: 39932052 PMC: 11811884. DOI: 10.1002/cam4.70634.


Nomogram for predicting the early death of patients with stage IV ovarian cancer: a retrospective analysis of the SEER database.

Chen P, Zheng S, Zhang L Transl Cancer Res. 2024; 13(11):5845-5855.

PMID: 39697763 PMC: 11651799. DOI: 10.21037/tcr-24-625.


Risk-stratified CA125 screening integrating CA125 trajectories, trajectory-specific progression and transvaginal ultrasound for ovarian cancer.

Duan H, Liu X, Zhang Y, Liu Y, Ji Y, Zhang Y J Ovarian Res. 2024; 17(1):210.

PMID: 39462415 PMC: 11514894. DOI: 10.1186/s13048-024-01535-9.


Risk Factors for Ovarian Cancer in South America: A Literature Review.

Jara-Rosales S, Gonzalez-Stegmaier R, Rotarou E, Villarroel-Espindola F J Pers Med. 2024; 14(9).

PMID: 39338246 PMC: 11433525. DOI: 10.3390/jpm14090992.


References
1.
Tworoger S, Eliassen A, Missmer S, Baer H, Rich-Edwards J, Michels K . Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2006; 15(12):2494-501. DOI: 10.1158/1055-9965.EPI-06-0671. View

2.
Skates S, Greene M, Buys S, Mai P, Brown P, Piedmonte M . Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials. Clin Cancer Res. 2017; 23(14):3628-3637. PMC: 5726402. DOI: 10.1158/1078-0432.CCR-15-2750. View

3.
Hogervorst J, Schouten L, Konings E, Goldbohm R, van den Brandt P . A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16(11):2304-13. DOI: 10.1158/1055-9965.EPI-07-0581. View

4.
Liu Z, Zhang T, Zhao J, Qi S, Du P, Liu D . The association between overweight, obesity and ovarian cancer: a meta-analysis. Jpn J Clin Oncol. 2015; 45(12):1107-15. DOI: 10.1093/jjco/hyv150. View

5.
Mayr D, Hirschmann A, Lohrs U, Diebold J . KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants. Gynecol Oncol. 2006; 103(3):883-7. DOI: 10.1016/j.ygyno.2006.05.029. View